Leading experts at Rutgers and Tel Aviv Universities hosted a symposium centered on the coronavirus pandemic and the research, response and lessons learned through the COVID-19 outbreak in the sister states of New Jersey and Israel. The virtual event was the first in a monthly series of joint scientific symposia and a broader research-based collaboration between the two universities.
Rutgers-led study NJ HEROES TOO focuses on the Black and Latinx communities disproportionately affected by COVID-19 in places where Rutgers academic medical centers are deeply rooted
A mobile application developed by researchers Joel Caplan and Leslie Kennedy at Rutgers University aims to protect first responders and healthcare workers by identifying environmental factors that could be contagion vectors among COVID-19 positive cases.
A team of Rutgers professors developed the COVID Nearby app to help monitor the spread of coronavirus with a guarantee of privacy to individuals reporting information. The app will also provide researchers with insights about the privacy preferences of individuals during health emergencies.
Amid the continuous need for COVID-19 test kits, Rutgers technologies once again prove invaluable to the fight against the pandemic that is sweeping the nation and the world. A recent COVID-19 rapid test that received FDA emergency use authorization includes molecular beacons technology, invented by Rutgers researchers.